menu
    • menu

    Company profile for Zhejiang Doer Biologics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Founded in 2014, Zhejiang Doer Biologics Co., Ltd is a clinical-stage biopharmaceutical company with its R&D center located in Hangzhou, China.Powered by its proprietary xLONGylation, MultipleBody, AccuBody, and SMART-VHHBody technology platforms, Doer Biologics is developing innovative multi-domain based multi-specific therapeutic proteins. Doer Biologics' highly differentiated pipeline focuses on unmet clinical...
    Founded in 2014, Zhejiang Doer Biologics Co., Ltd is a clinical-stage biopharmaceutical company with its R&D center located in Hangzhou, China.Powered by its proprietary xLONGylation, MultipleBody, AccuBody, and SMART-VHHBody technology platforms, Doer Biologics is developing innovative multi-domain based multi-specific therapeutic proteins. Doer Biologics' highly differentiated pipeline focuses on unmet clinical needs in the fields of cancer, endocrinology, metabolic diseases, and ophthalmology.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Zhejiang Doer BiologicsChina Flag
    Country
    Country
    China
    Address
    Address
    Floor 2,Building 3, Hexiang Science and Technology Center, Phase 3, Medicine P...
    Telephone
    Telephone
    0571-28256206
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.doerbio.com/English.php
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Doer Biologics Announces 1st Patient Dosed in Ph 2 Study of DR10624
    Doer Biologics Announces 1st Patient Dosed in Ph 2 Study of DR10624

    23 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/doer-biologics-announces-first-patient-dosed-in-phase-2-study-of-dr10624-for-treatment-of-metabolic-dysfunction-associated-steatotic-liver-disease-and-metabolic-dysfunction-associated-steatohepatitis-302435526.html

    PR NEWSWIRE
    23 Apr 2025
    Share Share
    Doer Completes Ph2 Enrollment Of DR10624 In Hypertriglyceridemia
    Doer Completes Ph2 Enrollment Of DR10624 In Hypertriglyceridemia

    09 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/doer-biologics-completes-enrollment-of-the-phase-2-clinical-study-of-dr10624-for-treatment-of-severe-hypertriglyceridemia-302396512.html

    PR NEWSWIRE
    09 Mar 2025
    Share Share
    Doer Biologics Doses First Patient In Ph 2 DR10624 Study
    Doer Biologics Doses First Patient In Ph 2 DR10624 Study

    30 Sep 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/doer-biologics-announces-first-patient-dosed-in-phase-2-study-of-dr10624-for-treatment-of-severe-hypertriglyceridemia-302262301.html

    PR NEWSWIRE
    30 Sep 2024
    Share Share
    Zhejiang Completes Enrollment of Phase 1b/2a Trial Evaluating DR10624 in Obese
    Zhejiang Completes Enrollment of Phase 1b/2a Trial Evaluating DR10624 in Obese

    05 Jul 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/zhejiang-doer-biologics-completes-enrollment-of-the-phase-1b2a-trial-evaluating-dr10624-in-obese-subjects-with-modest-hypertriglyceridemia-302189900.html

    PR NEWSWIRE
    05 Jul 2024
    Share Share
    Doer Announces First Subject Dosed in MAD Trial of DR10624
    Doer Announces First Subject Dosed in MAD Trial of DR10624

    01 Aug 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/doer-biologics-announces-first-subject-dosed-in-phase-i-12-week-multiple-ascending-dose-mad-clinical-trial-of-dr10624-and-received-ind-approval-from-nmpa-301890125.html

    PR NEWSWIRE
    01 Aug 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search